Insider · CIK 0001325697
Deborah J Andrews
Files at STAA (STAAR SURGICAL CO), LCTX (Lineage Cell Therapeutics, Inc.). First filing -, latest -.
Deborah J Andrews files SEC Form 4 as CFO, director and CEO at STAA (STAAR SURGICAL CO), and also at LCTX (Lineage Cell Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Deborah J Andrews has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 23 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | STAA STAAR SURGICAL CO | MOption exercise Common Stock | +5,233 | $0.00 | $0 | 41,452 | Aug 18, 2026 |
| Aug 14, 2026 | STAA STAAR SURGICAL CO | FTax withholding Common Stock | -2,662 | $26.18 | $70k | 38,910 | Aug 18, 2026 |
| Aug 14, 2026 | STAA STAAR SURGICAL CO | AGrant or award Restricted Stock Unitsderivative | +4,975 | $0.00 | $0 | 4,975 | Aug 18, 2026 |
| Aug 14, 2026 | STAA STAAR SURGICAL CO | AGrant or award Stock Option (right to buy)derivative | +8,952 | $0.00 | $0 | 8,952 | Aug 18, 2026 |
| Aug 14, 2026 | STAA STAAR SURGICAL CO | AGrant or award Performance Stock Option (right to buy)derivative | +29,159 | $0.00 | $0 | 29,159 | Aug 18, 2026 |
| Aug 14, 2026 | STAA STAAR SURGICAL CO | MOption exercise Performance Stock Unitsderivative | +5,233 | $0.00 | $0 | 41,452 | Aug 18, 2026 |
| Jun 25, 2026 | STAA STAAR SURGICAL CO | MOption exercise Common Stock | +13,955 | - | - | 32,608 | Aug 4, 2026 |
| Jun 25, 2026 | STAA STAAR SURGICAL CO | FTax withholding Common Stock | -6,480 | $31.21 | $202k | 26,128 | Aug 4, 2026 |
| Jul 31, 2026 | STAA STAAR SURGICAL CO | MOption exercise Common Stock | +20,787 | - | - | 46,915 | Aug 4, 2026 |
| Jul 31, 2026 | STAA STAAR SURGICAL CO | FTax withholding Common Stock | -10,576 | $24.36 | $258k | 36,339 | Aug 4, 2026 |
| Jun 25, 2026 | STAA STAAR SURGICAL CO | MOption exercise Restricted Stock Unitsderivative | -13,955 | $0.00 | $0 | 27,912 | Aug 4, 2026 |
| Jul 31, 2026 | STAA STAAR SURGICAL CO | MOption exercise Restricted Stock Unitsderivative | -20,787 | $0.00 | $0 | 0 | Aug 4, 2026 |
| Jul 1, 2026 | LCTX Lineage Cell Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Jul 2, 2026 |
| May 15, 2026 | STAA STAAR SURGICAL CO | AGrant or award Common Stock | +10,466 | $0.00 | $0 | 10,466 | May 19, 2026 |
| May 15, 2026 | STAA STAAR SURGICAL CO | FTax withholding Common Stock | -3,755 | $32.07 | $120k | 15,297 | May 19, 2026 |
| May 15, 2026 | STAA STAAR SURGICAL CO | AGrant or award Common Stock | +5,233 | $0.00 | $0 | 20,530 | May 19, 2026 |
| May 15, 2026 | STAA STAAR SURGICAL CO | FTax withholding Common Stock | -1,877 | $32.07 | $60k | 18,653 | May 19, 2026 |
| May 15, 2026 | STAA STAAR SURGICAL CO | MOption exercise Performance Stock Unitsderivative | +10,466 | $0.00 | $0 | 10,466 | May 19, 2026 |
| May 15, 2026 | STAA STAAR SURGICAL CO | MOption exercise Performance Stock Unitsderivative | +5,233 | $0.00 | $0 | 15,699 | May 19, 2026 |
| Mar 13, 2026 | STAA STAAR SURGICAL CO | AGrant or award Restricted Stock Unitsderivative | +39,809 | $0.00 | $0 | 39,809 | Mar 16, 2026 |
| Feb 2, 2026 | STAA STAAR SURGICAL CO | AGrant or award Restricted Stock Unitsderivative | +20,787 | $0.00 | $0 | 20,787 | Feb 4, 2026 |
| Jul 1, 2025 | LCTX Lineage Cell Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Jul 2, 2025 |
| Jun 25, 2025 | STAA STAAR SURGICAL CO | AGrant or award Restricted Stock Unitsderivative | +41,867 | $0.00 | $0 | 41,867 | Jun 26, 2025 |
Questions about Deborah J Andrews
Answered from the filings on this page, as of the latest one.
Is Deborah J Andrews buying or selling?
Deborah J Andrews has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Deborah J Andrews's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Deborah J Andrews has 0.
Where does Deborah J Andrews file Form 4?
Deborah J Andrews has filed Form 4 at STAA (STAAR SURGICAL CO) as Chief Financial Officer & EVP; LCTX (Lineage Cell Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.